APA

Pascoal T. A., Mathotaarachchi S., Mohades S., Benedet A. L., Chung C., Shin M., Wang S., Beaudry T., Kang M. S., Soucy J., Labbe A., Gauthier S. & Rosa-Neto P. (20171003). Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease. : Molecular psychiatry.

Chicago

Pascoal T A, Mathotaarachchi S, Mohades S, Benedet A L, Chung C-O, Shin M, Wang S, Beaudry T, Kang M S, Soucy J-P, Labbe A, Gauthier S and Rosa-Neto P. 20171003. Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease. : Molecular psychiatry.

Harvard

Pascoal T. A., Mathotaarachchi S., Mohades S., Benedet A. L., Chung C., Shin M., Wang S., Beaudry T., Kang M. S., Soucy J., Labbe A., Gauthier S. and Rosa-Neto P. (20171003). Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease. : Molecular psychiatry.

MLA

Pascoal T A, Mathotaarachchi S, Mohades S, Benedet A L, Chung C-O, Shin M, Wang S, Beaudry T, Kang M S, Soucy J-P, Labbe A, Gauthier S and Rosa-Neto P. Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease. : Molecular psychiatry. 20171003.